In our study, we observed significant differences in apoA-I and apoB levels across IS subtypes, with ICAS patients exhibiting distinct alterations compared to ECAS and SAO patients, highlighting the potential involvement of these apolipoproteins in the progression of intracranial atherosclerosis. This evidence concerns the gene APOA1 and southeast Asian ovalocytosis.